ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996

DCT to Fund 11 Surgical Oncology Grants. Consider Switching $700,000 To Program Project Renewals

November 2, 1979

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

Perifosine Increases PFS In Phase II Study

December 30, 2011

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004